Primary Care Clinics in Saratoga, WY Accepting Medicare
4 Primary Care Clinics found. Showing 1 - 4
 Platte Valley Medical Clinic, Pc Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 1208 S. River St, Saratoga, WY 82331 Phone: 307-326-8381 Fax: 307-326-5698 |
Platte Valley Medical Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1208 S River St, Saratoga, WY 82331 Phone: 307-326-8381 |
Platte Valley Clinic Inc. Clinic/Center Medicare: Medicare Enrolled Practice Location: 1208 S River Street, Saratoga, WY 82331 Phone: 406-655-1883 |
Platte Valley Medical Clinic Pc Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 1208 South River Street, Saratoga, WY 82331 Phone: 307-326-8381 Fax: 307-326-5698 |
News Archive
Challenges faced in cardiac imaging
When patients present with chest pain or other high-risk symptoms of heart problems, doctors increasingly rely on nuclear imaging and computed tomography (CT) tests to find out whether there is evidence of heart disease, blockages in the coronary arteries or reduced blood flow to the heart. Results of these procedures can help guide life-saving prevention and treatment options.
Long-term complications are common among COVID-19 recovered individuals
A team of scientists from the United Kingdom has recently conducted a multicenter, prospective cohort study to investigate long-term consequences of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Preclinical data from Idera's autoimmune and inflammatory disease program presented at 74th ACR
Idera Pharmaceuticals, Inc. today announced two presentations of preclinical data from its autoimmune and inflammatory disease program at the 74th Annual Scientific Meeting of the American College of Rheumatology (ACR) in Atlanta, Georgia. One presentation is entitled "IMO-3100, a Toll-like Receptor (TLR) Antagonist, Suppresses TLR7- and TLR9-mediated Immune Responses in Non-human Primates" (#856).
EnteroMedics to reduce its workforce and operating costs
EnteroMedics Inc., today announced that it has implemented a plan to reduce its workforce and operating costs in order to preserve capital and streamline its operations following the announcement of top-line results from its pivotal EMPOWER study on October 2, 2009. The reduction in force will lower the number of employees by 40%, to a total of 33, by November 15, 2009.
Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved a new use of Avastin (bevacizumab) in combination with fluoropyrimidine-based irinotecan or oxaliplatin chemotherapy for people with metastatic colorectal cancer (mCRC).
› Verified 8 days ago